27-hydroxycholesterol has been researched along with Cell Transformation, Neoplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, L; Chen, Y; Corley, CD; Fang, Y; Kumar, A; Luo, M; Luo, W; McDonald, JG; Nelson, ER; Wang, C; Wang, JE; Wang, Y; Xing, C; Xue, Y; Zhang, B | 1 |
1 other study(ies) available for 27-hydroxycholesterol and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells.
Topics: Animals; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Transformation, Neoplastic; Cholesterol; Epigenesis, Genetic; Female; Humans; Hydroxycholesterols; Mice; Neoplastic Stem Cells | 2022 |